Improving Cognitive Health in COVID-19 Survivors

PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

July 13, 2021

Primary Completion Date

February 6, 2023

Study Completion Date

April 26, 2023

Conditions
Cognitive DysfunctionCovid19
Interventions
DEVICE

AKL-T01

AKL-T01 will be administered as a 6-week intervention. It is an algorithmically delivered iPad-based video game designed to improve cognitive health by targeting attention and attentional control processes.

Trial Locations (1)

10065

Weill Cornell Medicine, New York

All Listed Sponsors
collaborator

Akili Interactive Labs, Inc.

INDUSTRY

lead

Weill Medical College of Cornell University

OTHER